Diversify Advisory Services’s Ligand Pharmaceuticals LGND Stock Holding History

Diversify Advisory Services’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.37M	Buy	+7,956	New	+$1.87M	0.04%	352

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diversify Advisory Services's LGND Position: Q2 2026 in Review

Diversify Advisory Services opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 7,956 shares worth $2.37M. The stake represents 0.04% of the portfolio and ranks #352 among its holdings.

414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

Diversify Advisory Services held 7,956 shares of Ligand Pharmaceuticals worth $2.37M as of Q2 2026.
Ligand Pharmaceuticals was a new Diversify Advisory Services position in Q2 2026.
Ligand Pharmaceuticals made up 0.04% of Diversify Advisory Services's portfolio in Q2 2026, its #352 holding.
414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.